| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |